Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
1999 3
2000 3
2003 4
2005 1
2006 2
2007 2
2008 2
2009 4
2010 3
2011 4
2012 5
2013 6
2014 7
2015 8
2016 3
2017 3
2018 6
2019 2
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Primary progressive MS.
Kremenchutzky M. Kremenchutzky M. Int MS J. 2003 Aug;10(3):89-95. Int MS J. 2003. PMID: 14561375 Review. No abstract available.
Autonomic dysfunction in multiple sclerosis.
Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M. Racosta JM, et al. Among authors: kremenchutzky m. Auton Neurosci. 2015 Dec;193:1-6. doi: 10.1016/j.autneu.2015.06.001. Epub 2015 Jun 7. Auton Neurosci. 2015. PMID: 26070809 Review.
The natural history of multiple sclerosis.
Deshpande R, Kremenchutzky M, Rice GP. Deshpande R, et al. Among authors: kremenchutzky m. Adv Neurol. 2006;98:1-15. Adv Neurol. 2006. PMID: 16400823 Review. No abstract available.
Cardiovascular autonomic dysfunction in multiple sclerosis: a meta-analysis.
Racosta JM, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M. Racosta JM, et al. Among authors: kremenchutzky m. Mult Scler Relat Disord. 2015 Mar;4(2):104-11. doi: 10.1016/j.msard.2015.02.002. Epub 2015 Feb 23. Mult Scler Relat Disord. 2015. PMID: 25787186 Review.
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
O'Connor PW, Kremenchutzky M. O'Connor PW, et al. Among authors: kremenchutzky m. Can J Neurol Sci. 2015 Nov;42(6):372-80. doi: 10.1017/cjn.2015.296. Epub 2015 Oct 27. Can J Neurol Sci. 2015. PMID: 26503087 Review. No abstract available.
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radü EW, Sørensen PS, King J. Kappos L, et al. Among authors: kremenchutzky m. Lancet Neurol. 2011 Aug;10(8):745-58. doi: 10.1016/S1474-4422(11)70149-1. Lancet Neurol. 2011. PMID: 21777829 Free article. Review.
62 results